Replimune Group Inc To Host Investor Day Transcript
Good morning, and thank you for joining our R&D investor event. We are excited to have this opportunity to share with everyone a number of important data and strategic program updates.
Before we begin, I need to highlight our forward-looking statement.
On Slide 3, I'm Philip Astley-Sparke, Chief Executive Officer of Replimune. And I have with me today from management, Robert Coffin, our President and Chief R&D Officer; and Sushil Patel, our Chief Commercial Officer. We're also very pleased to have with us today several leading physicians to present data and provide their insights on our development plan. This include Dr. Kevin Harrington, Professor in Biological Cancer Therapies at The Institute of Cancer Research, London, and Consultant Clinical Oncologist at The Royal Marsden; Dr. Nikhil Khushalani, Chief of Medical Oncology at the Moffitt Cancer Center; Dr. Muneeb Ahmed, Interventional Radiology Division Chief at the Beth Israel Deaconess, Associate Professor of Radiology at Harvard Medical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
